Statements in this press release regarding management's future
expectations, beliefs, intentions, goals, strategies, plans or prospects,
including statements relating to the CuraGen's pursuit of partnership
opportunities and discussion with potential partners, revenue, expenses,
depreciation, amortization, asset impairment charges, losses, income, and
future cash utilization and cash and investment positions, the timing and
expected results of its clinical programs, and the development and
marketability of planned drugs, may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements can be identified by terminology such as
"anticipate," "believe," "could," "could increase the likelihood,"
"estimate," "expect," "intend," "is planned," "may," "should," "will,"
"will enable," "would be expected," "look forward," "may provide," "would"
or similar terms, variations of such terms or the negative of those terms.
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors, including the risk that CuraGen's pursuit
of partnership opportunities will not proceed as planned or that any one or
more of CuraGen's drug development programs will not proceed as planned for
technical, scientific or commercial reasons or due to patient enrollment
issues or based on new information from nonclinical or clinical studies or
from other sources, as well as risk associated with the success of
competing products and technologies, Cu
|SOURCE CuraGen Corporation|
Copyright©2008 PR Newswire.
All rights reserved